UA85163C2 - Criptoblocking antibodies and use thereof - Google Patents

Criptoblocking antibodies and use thereof

Info

Publication number
UA85163C2
UA85163C2 UA20031110670A UA20031110670A UA85163C2 UA 85163 C2 UA85163 C2 UA 85163C2 UA 20031110670 A UA20031110670 A UA 20031110670A UA 20031110670 A UA20031110670 A UA 20031110670A UA 85163 C2 UA85163 C2 UA 85163C2
Authority
UA
Ukraine
Prior art keywords
antibodies
criptoblocking
antibody
relates
cripto
Prior art date
Application number
UA20031110670A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Микели Саникола-Надел
Кевин Уильямс
Сюзан Шиффир
Пол Рейхорн
Original Assignee
Байоджин Айдек Ма Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Байоджин Айдек Ма Инк. filed Critical Байоджин Айдек Ма Инк.
Publication of UA85163C2 publication Critical patent/UA85163C2/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The invention relates to the antibodies binding specifically with Cripto epitope. The invention also relates to the pharmaceutical formulation containing at least one of the antibodies, the application of antibody, and the method for modulating in vitro growth of cancer cells. The method comprises the stage of the addition of antibody to the sample.
UA20031110670A 2001-04-26 2002-04-17 Criptoblocking antibodies and use thereof UA85163C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28678201P 2001-04-26 2001-04-26

Publications (1)

Publication Number Publication Date
UA85163C2 true UA85163C2 (en) 2009-01-12

Family

ID=39621849

Family Applications (1)

Application Number Title Priority Date Filing Date
UA20031110670A UA85163C2 (en) 2001-04-26 2002-04-17 Criptoblocking antibodies and use thereof

Country Status (3)

Country Link
CN (1) CN101215332A (en)
UA (1) UA85163C2 (en)
ZA (2) ZA200308862B (en)

Also Published As

Publication number Publication date
ZA200606338B (en) 2009-09-30
CN101215332A (en) 2008-07-09
ZA200308862B (en) 2007-01-31

Similar Documents

Publication Publication Date Title
GEP20074091B (en) Cripto blocking antibodies and uses thereof
MXPA04006059A (en) Lyophilized preparation containing antibodies to the egf receptor.
UA85993C2 (en) Conjugate of a bacterial superantigen and antibody moiety, pharmaceutical composition containing thereof and method for treatment of cancer in mammals
AR035977A1 (en) IMMUNOCONJUGADOS OF ANTIBODIES CD44 CITOTOXICOS.
EP2221317A3 (en) PEGylated single domain antibodies (dAb)
ATE502053T1 (en) RECOMBINANT TUMOR-SPECIFIC ANTIBODIES AND USE THEREOF
WO2004055164A3 (en) System and method for stabilizing antibodies with histidine
ZA975851B (en) Hepatocyte grown factor receptor agonists and uses thereof
WO2004058171A3 (en) Antibodies against gpr64 and uses thereof
YU28503A (en) Humanized anti-lt-betha-r antibodies
AU3438900A (en) Use of trehalose for stabilising a liquid vaccine
IL214325A (en) Anti-cmet antibody, composition comprising it and use thereof
PT1157042E (en) Production of tetravalent antibodies
HK1074670A1 (en) Sets of digital antibodies directed against short epitopes, and methods using same
MY136095A (en) Use of human anti-ctla-4 antibodies for treatment of cancer
SG150550A1 (en) Pharmaceutical preparation containing an antibody for the egf receptor
NZ594466A (en) Human monoclonal antibodies to protein tyrosine kinase 7 (PTK7) and methods for using anti-PTK7 antibodies
TNSN08511A1 (en) Lyophilized formulations of anti-egfr antibodies
WO2003075855A3 (en) Antibodies against cancer antigen tmeff2 and uses thereof
WO2001098357A3 (en) Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulations
EP3941945A4 (en) Anti-trophoblast cell surface antigen 2 (trop2) antibodies and antibody drug conjugates comprising same
ES2009140A6 (en) Cross-protective human monoclonal antibody compositions
EP1354896A4 (en) Novel monoclonal antibody
WO2004067564A3 (en) Compositions against cancer antigen liv-1 and uses thereof
AU2002365269A1 (en) Mut-il-18 or mut-il-18r proteins, antibodies, compositions, methods and uses